Interesting facts
Interesting Facts about (2R,3R,4S,5R)-2-[6-(2-Furylmethylamino)purin-9-yl]-5-(Hydroxymethyl)Tetrahydrofuran-3,4-diol
This compound, with its complex structure, embodies the fascinating intersection of organic chemistry and medicinal applications. Here are some notable aspects:
- Structural Complexity: The presence of multiple stereocenters in this compound contributes to its intricate three-dimensional configuration. The notation (2R,3R,4S,5R) indicates specific stereochemical orientations, which can significantly influence the compound's biological activity.
- Biological Relevance: Compounds similar to this one are often explored in the context of their potential therapeutic effects, particularly in relation to their interactions with biological molecules such as nucleic acids.
- Aromatic Characteristics: The incorporation of a furylmethyl group introduces aromatic properties, facilitating interactions that are crucial in drug design and targeting.
- Hydroxymethyl Groups: The presence of hydroxymethyl groups provides sites for hydrogen bonding, potentially enhancing the compound's solubility and reactivity in biological systems.
- Research Potential: With ongoing advancements in medicinal chemistry, this compound may serve as a lead structure for the development of new pharmaceuticals addressing various diseases, including cancer and viral infections.
Overall, the significance of (2R,3R,4S,5R)-2-[6-(2-furylmethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol lies not just in its structural elegance, but also in its prospective implications for drug discovery and therapeutic innovation.
Synonyms
Kinetin riboside
4338-47-0
N6-Furfuryladenosine
N-(2-Furanylmethyl)adenosine
N(sup 6)-Furfuryladenosine
EINECS 224-389-3
BRN 0059588
Adenosine, N-(2-furanylmethyl)-
DTXSID20874669
4-26-00-03686 (Beilstein Handbook Reference)
(2R,3R,4S,5R)-2-[6-(furan-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-(furan-2-ylmethylamino)purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
KR (Kinetin riboside)
6-Furfuryladenine riboside
DTXCID601012795
Adenosine, N-(2-furanylmethyl)-(9CI)
caglgynqqsiugx-uhfffaoysa-n
nocas_874669
6-Furfurylaminopurine riboside
Ribosylkinetin
MFCD00037987
CHEMBL411066
(2R,3R,4S,5R)-2-(6-((Furan-2-ylmethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
NSC 120958
N6-(2-Furanyl-methyl)adenosine
N-(2-Furanylmethyl)-1H-purin-6-amine riboside
Kinetin-9-riboside
Spectrum_001277
SpecPlus_000551
Spectrum2_001453
Spectrum3_001101
Spectrum4_001930
Spectrum5_000687
BSPBio_002802
KBioGR_002280
KBioSS_001757
MLS002207023
(-)-KINETIN RIBOSIDE
DivK1c_006647
SPBio_001345
SCHEMBL3190252
N6-(2-furanylmethyl)-adenosine
CHEBI:95050
KBio1_001591
KBio2_001757
KBio2_004325
KBio2_006893
KBio3_002022
(2R,3R,4S,5R)-2-(6-(furan-2-ylmethylamino)-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol
BDBM50241447
CCG-38867
AKOS024282559
CS-6377
NK06717
SDCCGMLS-0066656.P001
(2R,3R,4S,5R)-2-{6-[(furan-2-ylmethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol
(3S,2R,4R,5R)-5-{6-[(2-furylmethyl)amino]purin-9-yl}-2-(hydroxymethyl)oxolane- 3,4-diol
SMP1_000170
NCGC00017361-02
NCGC00017361-03
NCGC00017361-04
NCGC00142491-01
NCGC00142491-02
NCGC00142491-03
AS-76879
DA-74766
SMR001223878
HY-101055
F12926
SR-05000002609
SR-05000002609-1
BRD-K94325918-001-02-0
BRD-K94325918-001-05-3
Q27166818
Kinetin riboside, proapoptotic anitproliferative plant growth regulator
(2R,3R,4S,5R)-2-[6-(2-furanylmethylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol
6-Furfurylaminopurine riboside;N6-Furfuryladenosine;9-(b-D-RibofuranosyI)-6-furfuryIaminopurine
Solubility of (2R,3R,4S,5R)-2-[6-(2-furylmethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
The solubility of this compound can be influenced by various factors due to its complex structure. Understanding its solubility is crucial for applications in pharmaceuticals and biochemistry. Here are some key points to consider:
In summary, while specific solubility data may not be readily available, the structural features of (2R,3R,4S,5R)-2-[6-(2-furylmethylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol indicate that it should be soluble in polar solvents due to its functional groups. Further empirical testing is recommended to quantify solubility under various conditions.